Yoshiharu Ohno1,2, Masao Yui3, Kota Aoyagi3, Yoshimori Kassai3, Daisuke Takenaka4, Kazuhiro Murayama1, and Takeshi Yoshikawa2
1Radiology, Fujita Health University School of Medicine, Toyoake, Japan, 2Radiology, Kobe University Graduate School of Medicine, Kobe, Japan, 3Canon Medical Systems Corporation, Otawara, Japan, 4Diagnostic Radiology, Hyogo Cancer Center, Akashi, Japan
Synopsis
Direct comparison of non-small cell lung cancer (NSCLC) recurrence
evaluation among these four methods in large prospective cohort more than 400
patients had not been reported. We
hypothesize that whole-body MRI as well as PET/MRI had better potential for
postoperative NSCLC recurrence than PET/CT and standard radiological
examination in large prospective cohort.
The purpose of this study was thus to compare the diagnostic performance
of whole-body MRI, PET/MRI, PET/CT and standard radiological examination for
postoperative NSCLC recurrence assessment in large prospective cohort more than
400 patients.
Introduction
Postoperative recurrence evaluation is
important for improving patients’ survival and quality of life in non-small
cell lung cancer (NSCLC) patients. For a
few decades, detection of recurrent disease using standard radiological examinations
such as chest radiograph and/or computed tomography (CT) remained difficult,
but positron emission tomography (PET) with [18F] fluoro-2-D-glucose as well as
PET combined with CT (PET/CT) have been found to be more effective than standard
radiological examination. In addition,
it has been suggested that whole-body magnetic resonance imaging (MRI) and PET
fused with MRI (PET/MRI) have been suggested as useful for staging and
recurrence assessment in NSCLC patients since 2015 (1-3). However, studies directly compared among MRI,
PET/MRI, PET/CT or standard examination were tested in less than 100 patients
(2, 3). Therefore, no direct comparison
of NSCLC recurrence evaluation among these four methods in large prospective
cohort more than 400 patients had been reported. We hypothesize that whole-body MRI as well as
PET/MRI had better potential for postoperative NSCLC recurrence than PET/CT and
standard radiological examination in large prospective cohort. The purpose of this study was thus to compare
the diagnostic performance of whole-body MRI, PET/MRI, PET/CT and standard
radiological examination for postoperative NSCLC recurrence assessment in large
prospective cohort more than 400 patients.Materials and Methods
484 consecutive postoperative NSCLC patients
(289 men, 195 women; mean age 69 years) prospectively underwent whole-body MRI
at a 3T system (Vantage Titan 3T, Canon Medical Systems Corporation, Otawara,
Japan), integrated PET/CTs and standard radiological guideline based on International
Association for the Study of Lung Cancer guideline as well as follow-up or
pathological examinations. Then, all
patients were divided into recurrence (n=42) and non-recurrence (n=442) groups
based on pathological and follow-up examinations. All co-registered PET/MRIs were generated by
means of our proprietary software. Then,
probability postoperative recurrence in each patient was visually assessed on
all methods by means of 5-point visual scoring system. To compare diagnostic performance among all
methods, receiver operating characteristic analyses were performed. Then, diagnostic accuracy of postoperative
recurrence was statistically compared each other by using McNemar’s test. Agreements were considered as poor for κ<
0.21, fair for κ = 0.21–0.40, moderate for κ = 0.41–0.60, substantial for κ =
0.61–0.80, and excellent for κ = 0.81–1.00.
A p value < 0.05 was considered statistically significant for all
statistical analyses.Results
Representative case is shown in Figure 1 and 2. Interobserver agreements for postoperative
recurrence on all methods were substantial (MRI: κ=0.64, p<0.0001; PET/MRI:
κ=0.67, p<0.0001; PET/CT: κ=0.68, p<0.0001; standard radiological
examination: κ=0.67, p<0.0001).
Results of ROC analysis and McNemar’s test are shown in Figure 3. Area under the curve (AUC) of PET/MRI
(AUC=0.99, p<0.05) were significantly larger than that of others (MRI:
AUC=0.97, PET/CT: AUC=0.97, standard radiological examination: AUC=0.94). Sensitivity (SE), specificity (SP) or
accuracy (AC) of PET/MRI (SE: 92.9%, SP: 98.2%, AC: 97.7%) were significantly
higher than that of MRI (SE: 76.2%, p<0.05; AC: 96.3%, p<0.05), PET/CT
(SP: 95.5%, p<0.05; AC: 94.8%, p<0.05) and standard radiological
examination (SP: 90.5%, p<0.05; AC: 90.0%, p<0.05). In addition, SP (98.2%) and AC of MRI were
significantly higher than those of PET/CT and standard radiological examination
(p<0.05). Moreover, SP and AC of
PET/CT were significantly higher than those of standard radiological
examination (p<0.05). Conclusion
Whole-body MRI as well as PET/MRI have significantly
better potential for postoperative NSCLC recurrence evaluation than PET/CT and
standard radiological examination, although PET/MRI can improve diagnostic
performance of MRI in large prospective cohort.Acknowledgements
Authors wish to thank Mr. Katsusuke Kyotani and
Prof. Takamichi Murakami in Kobe University Hospital for their valuable
contributions to this study. References
- Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J. J Magn
Reson Imaging. 2015; 42(2): 247-260.
- Ohno Y, Koyama H, Yoshikawa T, et al. Radiology. 2015; 275(3):
849-861.
-
Ohno Y,
Yoshikawa T, Kishida Y, et al. J Magn Reson Imaging. 2017; 46(6): 1707-1717.